1. 安藤 文隆. 糖尿病網膜症の治療の進歩 血管新生緑内障の治療. 眼科39(1):41-47 (1997).
2. 松本 行弘, 高橋 一, 西尾 正, 筑田 眞. 血管新生緑内障の長期治療成績. 眼科臨床医報 93 (7):990-994 (1999).
3. 大越 貴志子. わかりやすい臨床講座 網膜光凝固 過去 現在 未来. 日本の眼科87 (11):1485-1491 (2016).
4. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 88 (7):583-600 (1981).
5. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103 (12):1796-1806 (1985).
6. Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S. Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 24 (4):507-511 (2004).
7. Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109 (11):1549-1551 (1991).
8. Varley MP, Frank E, Purnell EW. Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology 95 (5):567-573 (1988).
9. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 113 (4):456-462 (1995).
10. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 126 (2):219-229 (1998).
11. Shiraya T, Kato S, Shigeeda T, Fukushima H. Vitreous hemorrhage and fibrovascular proliferation after laser-induced chorioretinal venous anastomosis. Int J Ophthalmol 4 (2):216-217 (2011).
12. Browning DJ, Antoszyk AN. Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 105 (4):670-677; discussion 677-679 (1998).
13. Writing Committee for the Diabetic Retinopathy Clinical Research N, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 125 (4):469-480 (2007).
14. Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, Nam DH. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 152 (4):686-694 (2011).
15. Shiraya T, Kato S, Araki F, Ueta T. Effect of intravitreal ranibizumab injection on aqueous humour cytokine levels in patients with diabetic macular oedema. Acta Ophthalmol(2016).
16. Shiraya T, Kato S, Araki F, Ueta T, Miyaji T, Yamaguchi T. Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema. PLoS One 12 (3):e0174340 (2017).
17. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, group Rs. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118 (4):615-625 (2011).
18. Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM. Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121 (11):2247-2254 (2014).
19. Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ, Ride, Group RR. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120 (10):2013-2022 (2013).
20. Diabetic Retinopathy Clinical Research N, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372 (13):1193-1203 (2015).
21. Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW, Diabetic Retinopathy Clinical Research N. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology 123 (6):1351-1359 (2016).
22. Blumenkranz MS, Yellachich D, Andersen DE, Wiltberger MW, Mordaunt D, Marcellino GR, Palanker D. Semiautomated patterned scanning laser for retinal photocoagulation. Retina 26 (3):370-376 (2006).
23. Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (Lond) 22 (1):96-99 (2008).
24. Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 30 (3):452-458 (2010).
25. Modi D, Chiranand P, Akduman L. Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization. Clin Ophthalmol 3:465-470 (2009).
26. Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study. Arch Ophthalmol 128 (5):525-533 (2010).
27. Lavinsky D, Sramek C, Wang J, Huie P, Dalal R, Mandel Y, Palanker D. Subvisible retinal laser therapy: titration algorithm and tissue response. Retina 34(1):87-97 (2014).
28. Qiao G, Guo HK, Dai Y, Wang XL, Meng QL, Li H, Chen XH, Chen ZL. Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials. Int J Ophthalmol 9 (7):1020-1027 (2016).
29. Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K. Sublethal Photothermal Stimulation with a Micropulse Laser Induces Heat Shock Protein Expression in ARPE-19 Cells. J Ophthalmol 2015:729792 (2015).
30. Apple DJ. Harold Ridley, MA, MD, FRCS: a golden anniversary celebration and a golden age. Arch Ophthalmol 117 (6):827-828 (1999).
31. Miyata K, Otani S, Nejima R, Miyai T, Samejima T, Honbo M, Minami K, Amano S. Comparison of postoperative surface light scattering of different intraocular lenses. Br J Ophthalmol 93 (5):684-687 (2009).
32. Beheregaray S, Yamamoto T, Hiraoka T, Oshika T. Influence on visual function of forward light scattering associated with subsurface nanoglistenings in intraocular lenses. J Cataract Refract Surg 40 (7):1147-1154 (2014).
33. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 103 (10):1546-1554 (1996).
34. Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 110 (10):1960-1967 (2003).
35. Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina 27 (7):816-824 (2007).
36. Shiraya T, Kato S, Shigeeda T, Yamaguchi T, Kaiya T. Comparison of burn size after retinal photocoagulation by conventional and high-power short-duration methods. Acta Ophthalmol 92 (7):e585-586 (2014).
37. Shiraya T, Kato S, Araki F, Yamaguchi T, Kaiya T. Comparison of burn sizes resulting from photocoagulation using a transpupillary laser and an endolaser. Acta Ophthalmol(2015).
38. Paulus YM, Jain A, Gariano RF, Stanzel BV, Marmor M, Blumenkranz MS, Palanker D. Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci 49 (12):5540-5545 (2008).
39. Striga M, Ivanisevic M. Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis. Ophthalmologica 207 (3):144-147 (1993).
40. 木内 克治, 山田 晴, 河合 江, 藤関 義, 和田 光, 森口 佳, 津村 晶, 畑埜 浩,松村 美. 糖尿病網膜症による血管新生緑内障の目標とする光凝固数. 臨床眼科 57 (6):1099-1103 (2003).
41. Shiraya T, Kato S, Shigeeda T. Optimal area of retinal photocoagulation necessary for suppressing active iris neovascularisation associated with diabetic retinopathy. Int Ophthalmol 34 (5):1115-1117 (2014).
42. 野寄喜美春、清水弘一. レーザー眼治療. 医学書院:130-132 (1987).
43. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 85 (1):82-106 (1978).
44. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (5 Suppl):823-833 (1991).
45. Roider J, Michaud NA, Flotte TJ, Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 110 (12):1786-1792 (1992).
46. Roider J. Laser treatment of retinal diseases by subthreshold laser effects. Semin Ophthalmol 14 (1):19-26 (1999).
47. Shiraya T, Kato S, Araki F, Ueta T, Abe H, Asai N. Experimental verification of subthreshold laser therapy using conventional pattern scan laser. PLoS One 12 (9):e0184392 (2017).
48. Koinzer S, Saeger M, Hesse C, Portz L, Kleemann S, Schlott K, Brinkmann R, Roider J. Correlation with OCT and histology of photocoagulation lesions in patients and rabbits. Acta Ophthalmol 91 (8):e603-611 (2013).
49. Ohkoshi K, Yamaguchi T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am J Ophthalmol 149 (1):133-139 (2010).
50. Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30 (6):908-916 (2010).
51. Lavinsky D, Cardillo JA, Melo LA, Jr., Dare A, Farah ME, Belfort R, Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci 52 (7):4314-4323 (2011).
52. Takatsuna Y, Yamamoto S, Nakamura Y, Tatsumi T, Arai M, Mitamura Y. Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema. Jpn J Ophthalmol 55 (4):365-369 (2011).
53. Luttrull JK, Spink CJ. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg Lasers Imaging 37 (5):370-377 (2006).
54. Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 14 (4):200-209 (1999).
55. Sher A, Jones BW, Huie P, Paulus YM, Lavinsky D, Leung LS, Nomoto H, Beier C, Marc RE, Palanker D. Restoration of retinal structure and function after selective photocoagulation. J Neurosci 33 (16):6800-6808 (2013).
56. Miyata A, Yaguchi S. Equilibrium water content and glistenings in acrylic intraocular lenses. J Cataract Refract Surg 30 (8):1768-1772 (2004).
57. Matsushima H, Mukai K, Nagata M, Gotoh N, Matsui E, Senoo T. Analysis of surface whitening of extracted hydrophobic acrylic intraocular lenses. J Cataract Refract Surg 35 (11):1927-1934 (2009).
58. Ong MD, Callaghan TA, Pei R, Karakelle M. Etiology of surface light scattering on hydrophobic acrylic intraocular lenses. J Cataract Refract Surg 38 (10):1833-1844 (2012).
59. Hayashi K, Hirata A, Yoshida M, Yoshimura K, Hayashi H. Long-term effect of surface light scattering and glistenings of intraocular lenses on visual function. Am J Ophthalmol 154 (2):240-251 e242 (2012).
60. Hayashi K, Hayashi H, Nakao F, Hayashi F. In vivo quantitative measurement of posterior capsule opacification after extracapsular cataract surgery. Am J Ophthalmol 125 (6):837-843 (1998).
61. Minami K, Maruyama Y, Honbo M, Matsunaga J, Miyata K. In vitro examination of surface light scattering in hydrophobic acrylic intraocular lenses. J Cataract Refract Surg 40 (4):652-656 (2014).
62. Shiraya T, Kato S, Minami K, Miyata K. Influence of surface light scattering in hydrophobic acrylic intraocular lenses on laser beam transmittance. Int Ophthalmol(2016).
63. Yaguchi S, Nishihara H, Kambhiranond W, Stanley D, Apple DJ. Light scatter on the surface of AcrySof intraocular lenses: part I. Analysis of lenses retrieved from pseudophakic postmortem human eyes. Ophthalmic Surg Lasers Imaging 39 (3):209-213 (2008).
64. Werner L, Morris C, Liu E, Stallings S, Floyd A, Ollerton A, Leishman L, Bodnar Z. Light transmittance of 1-piece hydrophobic acrylic intraocular lenses with surface light scattering removed from cadaver eyes. J Cataract Refract Surg 40 (1):114-120 (2014).
65. Ogura Y, Ong MD, Akinay A, Carson DR, Pei R, Karakelle M. Optical performance of hydrophobic acrylic intraocular lenses with surface light scattering. J Cataract Refract Surg 40 (1):104-113 (2014).
66. Das KK, Stover JC, Schwiegerling J, Karakelle M. Technique for measuring forward light scatter in intraocular lenses. J Cataract Refract Surg 39 (5):770-778 (2013).
67. Leibovitch I, Lai T, Porter N, Pietris G, Newland H, Selva D. Visual outcomes with the yellow intraocular lens. Acta Ophthalmol Scand 84 (1):95-99 (2006).
68. Hayashi K, Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol 90 (8):1019-1023 (2006).
69. Vuori ML, Mantyjarvi M. Colour vision and retinal nerve fibre layer photography in patients with an Acrysof Natural intraocular lens. Acta Ophthalmol Scand 84 (1):92-94 (2006).
70. Shiraya T, Kato S, Shigeeda T. Influence of a yellow-tinted intraocular lens on laser beam transmittance. Acta Ophthalmol 89 (1):37-39 (2011).
71. Lerman S. Chemical and physical properties of the normal and aging lens: spectroscopic (UV, fluorescence, phosphorescence, and NMR) analyses. Am J Optom Physiol Opt 64 (1):11-22 (1987).
72. Yanagi Y, Inoue Y, Iriyama A, Jang WD. Effects of yellow intraocular lenses on light-induced upregulation of vascular endothelial growth factor. J Cataract Refract Surg 32 (9):1540-1544 (2006).